Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices by Fernandes, Mara Yone D. et al.
1
Vol.:(0123456789)
Scientific Reports |        (2021) 11:10488  | https://doi.org/10.1038/s41598-021-89964-0
www.nature.com/scientificreports
Neuromodulation 
and neuroprotective effects 
of chlorogenic acids in excitatory 
synapses of mouse hippocampal 
slices
Mara Yone D. Fernandes1,2, Fernando Dobrachinski1,3, Henrique B. Silva1, João Pedro Lopes1, 
Francisco Q. Gonçalves1, Felix A. A. Soares3, Lisiane O. Porciúncula4, Geanne M. Andrade2, 
Rodrigo A. Cunha1,5* & Angelo R. Tomé1,6
The increased healthspan afforded by coffee intake provides novel opportunities to identify new 
therapeutic strategies. Caffeine has been proposed to afford benefits through adenosine  A2A receptors, 
which can control synaptic dysfunction underlying some brain disease. However, decaffeinated coffee 
and other main components of coffee such as chlorogenic acids, also attenuate brain dysfunction, 
although it is unknown if they control synaptic function. We now used electrophysiological recordings 
in mouse hippocampal slices to test if realistic concentrations of chlorogenic acids directly affect 
synaptic transmission and plasticity. 3-(3,4-dihydroxycinnamoyl)quinic acid (CA, 1–10 μM) and 
5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic acid (NCA, 1–10 μM) were devoid of effect on synaptic 
transmission, paired-pulse facilitation or long-term potentiation (LTP) and long-term depression 
(LTD) in Schaffer collaterals-CA1 pyramidal synapses. However, CA and NCA increased the recovery of 
synaptic transmission upon re-oxygenation following 7 min of oxygen/glucose deprivation, an in vitro 
ischemia model. Also, CA and NCA attenuated the shift of LTD into LTP observed in hippocampal slices 
from animals with hippocampal-dependent memory deterioration after exposure to β-amyloid 1–42 
(2 nmol, icv), in the context of Alzheimer’s disease. These findings show that chlorogenic acids do not 
directly affect synaptic transmission and plasticity but can indirectly affect other cellular targets to 
correct synaptic dysfunction. Unraveling the molecular mechanisms of action of chlorogenic acids will 
allow the design of hitherto unrecognized novel neuroprotective strategies.
Abbreviations
A2AR  Adenosine  A2A receptor
Ab  β-amyloid peptide
ACSF  Artificial cerebrospinal fluid
CA  3-(3,4-Dihydroxycinnamoyl)quinic acid
fEPSP  Field excitatory post-synaptic potential
icv  Intra-cerebroventricular
LTP  Long-term potentiation
LFS  Low frequency stimulation
LTD  Long-term depression
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NCA  5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic acid
OGD  Oxygen–glucose deprivation
The regular consumption of moderate amounts of coffee affords a robust protection against age-associated 
chronic  diseases1–3, thus increasing healthspan on  ageing4. Brain diseases are a major burden of  disease5 and 
coffee intake dampens neuropsychiatric diseases with a robust inverse relation between coffee intake and mood-
related depressive  conditions6–8 as well as with cognitive  deterioration9–11. Caffeine is a major constituent of 
coffee involved in these neuroprotective  effects12, especially since animal studies have identified that caffeine and 
selective blockade of the molecular targets of caffeine—adenosine  A2A  receptors13,14—afford a robust protection 
against mood and memory dysfunction in animal models of brain  disease15. These protective effects of caffeine 
against brain dysfunction, have been linked to the ability of caffeine and  A2A receptor antagonists to fine-tune 
the function of synapses, namely controlling synaptic plasticity and preventing  synaptotoxicity16–18, a process 
which is at the core of the onset of  depression19 and memory-related dysfunction such as Alzheimer’s  disease20.
Importantly, coffee has a diversity of other bioactive constituents apart from caffeine, amongst which stem 
chlorogenic  acids21. As most polyphenols, chlorogenic acids have been described as potent  antioxidants22 and 
several studies have shown an ability of chlorogenic acids to affect brain  function23–27. Thus, interventions with 
diets enriched in chlorogenic acids ameliorate  mood22,23 and cognitive  function25,26 in volunteers. Moreover, 
mounting evidence indicates that the intake of chlorogenic acids decreases the incidence of different brain dis-
eases, such as  dementia27–30,  depression31,32 or brain  ischemia33–36. Additionally, cellular studies demonstrated 
cytoprotective and neuroprotective effect of chlorogenic  acids28,37–41. However, it has not yet been tested if chlo-
rogenic acids can directly affect synaptic function and/or attenuate synaptic dysfunction, which occurs at the 
onset of brain diseases.
With particular care to select realistic concentrations of chlorogenic acids, we now used electrophysiological 
approaches to probe the ability of two different chlorogenic acids abundant in coffee beverages to affect synaptic 
transmission and plasticity in neuronal circuits of hippocampal slices, which are frequently used as representa-
tive neuronal circuits. Furthermore, hippocampal circuits are modified under conditions of mood and memory 
dysfunction, allowing the assessment of possible effects of chlorogenic acids on synaptic deterioration in experi-
mental conditions modelling ischemia or Alzheimer’s disease.
Results
Effect of chlorogenic acids on synaptic transmission and plasticity. We first tested the effects of 
two different chlorogenic acids that are known to be abundantly present in coffee beverages on synaptic trans-
mission and plasticity under physiological-like conditions. We used hippocampal slices to isolate putative direct 
effects on synaptic function and we tested ‘realistic’ concentrations of chlorogenic acids (1–10 µM), within the 
reported concentrations of chlorogenic acids reached in the plasma, that are similar to these measured in the 
brain  parenchyma42 of volunteers ingesting chlorogenic acids in amounts equivalent to those found in  coffee43,44.
As shown in Fig. 1A,B, the superfusion of hippocampal slices with 3-(3,4-dihydroxycinnamoyl)quinic acid 
(CA, 1 or 10 µM) did not affect basal excitatory synaptic transmission (-1.18 ± 0.43% and 0.60 ± 0.95% modifi-
cation of fEPSP slope; p = 0.094 and p = 0.999 versus control, n = 6, Wilcoxon Signed Rank test). CA (1–10 µM) 
was also devoid of effects on the paired-pulse facilitation ratio, with an inter-pulse interval of 25 ms or 50 ms, 
indicating a lack of direct presynaptic effects (Fig. 1C). Moreover, CA (1–10 µM) did not affect the magnitude of 
long-term potentiation, LTP (62.81 ± 6.19% over baseline under control conditions without drugs, 54.83 ± 4.42% 
over baseline with 1 µM CA and 63.22 ± 5.36% over baseline with 10 µM CA; n = 9–12, p = 0.467 versus control, 
Kruskal Wallis test) (Fig. 1D–F).
As shown in Fig. 2A,B, the superfusion of hippocampal slices with 5-O-(trans-3,4-dihydroxycinnamoyl)-
D-quinic acid (neochlorogenic acid, NCA, 1 or 10 µM) did not affect basal excitatory synaptic transmission 
(0.80 ± 1.18% and 1.41 ± 0.78% modification of fEPSP slope; p = 0.438 and p = 0.250 versus control, n = 4–5, Wil-
coxon Signed Rank test). NCA (1–10 µM) was also devoid of effects on the paired-pulse facilitation ratio, with 
an inter-pulse interval of 25 ms or 50 ms, indicating a lack of direct presynaptic effects (Fig. 2C). Also, NCA 
(1–10 µM) did not affect LTP magnitude (62.33 ± 4.04% over baseline under control conditions without drugs, 
54.42 ± 6.29% over baseline with 1 µM NCA and 49.61 ± 5.04% over baseline with 10 µM NCA; n = 7–8, p = 0.204 
versus control, Kruskal Wallis test) (Fig. 2D–F).
Overall, these findings indicate a lack of direct effects of chlorogenic acids on synaptic function under physi-
ological conditions.
Effect of chlorogenic acids on ischemia-induced depression of synaptic transmission. To test if 
chlorogenic acids could prevent the deterioration of synaptic function, we next resorted to an in vitro model of 
ischemia-induced depression of synaptic transmission. Ischemia was modelled by exposing hippocampal slices 
to oxygen and glucose deprivation  (OGD45,46). Chlorogenic acids were applied at the onset of the re-oxygena-
tion period since our previous studies indicated an efficiency of polyphenolic compounds to prevent ischemia-
induced brain damage when applied after the onset of  ischemia47. This approach offers the opportunity to clearly 
distinguish putative effects exerted by chlorogenic acids from these of caffeine, which mostly affects the onset of 
ODG-induced depression of excitatory transmission in the  hippocampus48.
As shown in Fig. 3A, a 7 min period of OGD abolished synaptic transmission, which slightly recovered to 
11.18 ± 2.89% of pre-OGD values (n = 7) within 20–25 min of re-oxygenation in control slices. Notably, the 
addition of 10 µM CA at the onset of re-oxygenation increased the recovery of synaptic transmission upon re-
oxygenation to 39.49 ± 12.25% of pre-ischemic values (n = 8, p = 0.087 versus control, Dunn’s post hoc test after 
a Kruskal Wallis test) (Fig. 3A–D), although the data seemed to cluster into two distinct groups: some slices 
3
Vol.:(0123456789)
Scientific Reports |        (2021) 11:10488  | https://doi.org/10.1038/s41598-021-89964-0
www.nature.com/scientificreports/
recovered markedly (n = 4 out of 8), whereas other slices recovered poorly (n = 4 out of 8). The addition of 10 µM 
NCA at the onset of re-oxygenation allowed a more evident increased the recovery of synaptic transmission upon 
re-oxygenation to 74.96 ± 14.53% of pre-OGD values (n = 3, p = 0.019 versus control, Dunn’s post hoc test after 
a Kruskal Wallis test) (Fig. 3A–D).
This increased recovery of synaptic function following OGD in the presence of chlorogenic acids was further 
confirmed by the greater ability of hippocampal synapses to implement patterns of synaptic plasticity in slices 
treated with chlorogenic acids after OGD. Thus, as shown in Fig. 3E (which is a continuation of the recordings 
displayed in Fig. 3A, re-scaled to facilitate comparisons), control slices subject to OGD were essentially unable 
to increase their synaptic efficiency after application of a high-frequency train (100 Hz for 1 s) normally able 
to trigger LTP (e.g. Figure 1D–F) (-2.47 ± 1.52% of baseline value, n = 4, p = 0.087 versus baseline). In contrast, 
slices treated with 10 µM CA from re-oxygenation onwards after OGD, were able to display LTP (31.3 ± 8.47% 
of baseline value, n = 3, p = 0.023 versus control, Dunn’s post hoc test after a Kruskal Wallis test) (Fig. 3E–H). 
Likewise, slices treated from re-oxygenation onwards after OGD in the presence of 10 µM NCA were also able to 
display LTP (14.8 ± 2.01% of baseline value, n = 3), although LTP magnitude was not significantly different from 
control (p = 0.081 versus control, Dunn’s post hoc test after a Kruskal Wallis test) (Fig. 3E–H).
In conclusion, in spite of the reduced number of experiments, the overall qualitative analysis of the findings 
suggests an ability of chlorogenic acids to recover synaptic deterioration in this in vitro model of ischemia.
Effect of chlorogenic acids on alterations of synaptic plasticity in a model of Alzheimer’s dis-
ease. Two weeks after the icv administration of 2 nmol Aβ1-42, there was no difference in the number of 
crossings between vehicle-treated (control: 89.5 ± 7.07, n = 6) and Aβ-treated mice (87.5 ± 4.75, n = 6; p = 0.937 
versus control) in the open field test (Fig. 4A). This lack of altered locomotion was accompanied by an apparent 
Figure 1.  The chlorogenic acid 3-(3,4-dihydroxycinnamoyl)quinic acid (CA, 1 or 10 µM) did not affect either 
basal synaptic transmission or synaptic plasticity. CA (1 µM, light blue symbols or 10 µM, dark blue symbols) 
did not alter basal synaptic transmission (A), measured as the descending slope of field excitatory postsynaptic 
potentials (fEPSP) recorded extracellularly in the stratum radiatum of the CA1 area upon stimulation of the 
afferent Schaffer collaterals, illustrated as inserts in panel A. Likewise, CA (1 or 10 µM) did not modify the 
input–output responses (B) or the paired-pulse facilitation ratio, i.e. the ratio of the fEPSP slopes evoked by 
two consecutive pulses (ratio of P2/P1) with inter-pulse intervals of 25 or 50 ms (C). The average time course 
experiments of LTP induction (D), i.e. the variation of fEPSP slope over time upon induction of LTP with a 
high-frequency stimulation train (HFS: one train of 100 pulses of delivered at 100 Hz) in hippocampal slices 
untreated (control, black symbols) or treated with CA (1 or 10 µM), revealed that LTP magnitude was not 
affected by CA (F). (E) Representative fEPSP recorded in ACSF (control conditions, upper row) and in the 
presence of 10 µM CA (lower row) before (dashed traces) and 60 min after the HFS (filled traces). Data are 
mean ± S.E.M. of 6–12 experiments.
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lack of altered anxiety after Aβ exposure, as gauged by the similar time spent exploring the more aversive central 
area of the open field between vehicle-treated (control: 32.7 ± 2.40 s, n = 6) and Aβ-treated mice (32.2 ± 2.59 s, 
n = 6; p = 0.890 versus control) (Fig. 4B). In the object displacement test, the mice did not show a preference for 
the objects during training (data not shown), but Aβ-treated mice interacted less (p = 0.004) with the new object 
(56.7 ± 2.69% of total time, n = 6) than vehicle-treated mice (71.6 ± 3.00%, n = 6) (Fig.  4C). This Aβ-induced 
deterioration of hippocampal-dependent memory was confirmed using the modified Y maze: Aβ-treated mice 
entered less (p = 0.006) in the new and previously inaccessible arm (33.3 ± 3.36% of total entries, n = 6) than 
vehicle-treated mice (48.4 ± 2.62%, n = 6) (Fig. 4D).
In hippocampal slices from vehicle-treated mice, repeated trains of low-frequency stimulation (LFS) caused 
a long-term reduction of synaptic efficiency (Fig. 4E–F), corresponding to an LTD magnitude of -17.2 ± 3.14% 
(n = 6). LTD magnitude was not affected by 10 μM CA in slices from vehicle-treated mice (-13.8 ± 3.93%, n = 4; 
p = 0.909 versus control). In accordance with the previously reported shift from LTD-to-LTP associated with 
memory  dysfunction49, LFS caused a LTP instead of a LTD in slices from Aβ-treated mice (17.3 ± 3.13%, n = 5), 
which decreased in magnitude in the presence of 10 μM CA (1.23 ± 4.21%, n = 6; p = 0.022 versus Aβ-treated) 
(Fig. 4E–F). Indeed, a Dunn’s test after a Kruskal–Wallis test indicated an effect of Aβ exposure in the absence of 
CA (p < 0.002) on the magnitude of LFS-induced synaptic plasticity, a difference which was no longer significant 
in the presence of 10 μM CA (p = 0.749).
Similarly, NCA (10 μM) also failed to alter LTD magnitude in slices from vehicle-treated (-13.8 ± 3.93%, n = 4; 
p = 0.780 versus control), whereas it attenuated the LTD-to-LTP shift in slices from Aβ-treated mice (6.36 ± 3.73%, 
n = 5; p = 0.052 versus Aβ-treated) (Fig. 4G–H). A Dunn’s test after a Kruskal–Wallis test indicated an effect of 
Aβ exposure in the absence of NCA (p < 0.011) on the magnitude of LFS-induced synaptic plasticity, a difference 
which was no longer significant in the presence of 10 μM NCA (p = 0.101). Please note that the data correspond-
ing to control and Aβ-treated slices are the same for Figs. 4E–F and Figs. 4G–H.
These findings show that chlorogenic acids do not affect synaptic plasticity processes in ‘physiological’ condi-
tions but recover synaptic deterioration in this model of Alzheimer’s disease.
Figure 2.  The neochlorogenic acid 5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic acid (NCA, 1 or 10 µM) 
did not affect either basal synaptic transmission or synaptic plasticity. NCA (1 µM, light green symbols or 
10 µM, dark green symbols) did not alter basal synaptic transmission (A), measured as the descending slope 
of field excitatory postsynaptic potentials (fEPSP) recorded extracellularly in the stratum radiatum of the CA1 
area upon stimulation of the afferent Schaffer collaterals, illustrated as inserts in panel A. Likewise, NCA (1 or 
10 µM) did not modify the input–output responses (B) or the paired-pulse facilitation ratio, i.e. the ratio of the 
fEPSP slopes evoked by two consecutive pulses (ratio of P2/P1) with inter-pulse intervals of 25 or 50 ms (C). 
The average time course experiments of LTP induction (D), i.e. the variation of fEPSP slope over time upon 
induction of LTP with a high-frequency stimulation train (HFS: one train of 100 pulses delivered at 100 Hz) 
in hippocampal slices untreated (control, black symbols) or treated with NCA (1 or 10 µM), revealed that LTP 
magnitude was not affected by NCA (F). (E) Representative fEPSP recorded in ACSF (control conditions, upper 
row) and in the presence of 10 µM NCA (lower row) before (dashed traces) and 60 min after the HFS (filled 
traces). Data are mean ± S.E.M. of 4–8 experiments.
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Discussion
The present study provides the first description of the putative direct effects of chlorogenic acids on synaptic 
function. The results obtained show that chlorogenic acids do not affect either hippocampal synaptic transmission 
or synaptic plasticity under physiological conditions; however, when the synaptic function is perturbed, either 
upon ischemia-like conditions or upon exposure to β-amyloid peptides, chlorogenic acids were able to attenuate 
synaptic dysfunction, by increasing the recovery of synaptic transmission on re-oxygenation or dampening the 
abnormal shift of hippocampal synaptic plasticity associated with memory impairment caused by exposure to 
β-amyloid peptides.
Chlorogenic acids are abundant in several everyday foods such as fruits and vegetables as well as in bever-
ages, most prominently in  coffee21. The positive impact of coffee intake on human health has been revived by the 
conclusion that coffee intake increases healthspan on  ageing1–4 and is also inversely correlated with dysfunction 
of  mood6–8 and  memory9–11. Since mood and memory deterioration are now well established to involve modifi-
cations of synaptic function in afflicted brain  areas19,20, it becomes particularly relevant to establish how differ-
ent components of coffee beverages might affect synaptic function. Whereas a strong case has been made for a 
role of caffeine-mediated neuroprotection associated with the inhibition of synaptically-located adenosine  A2A 
Figure 3.  The chlorogenic acids 3-(3,4-dihydroxycinnamoyl)quinic acid (CA, 10 µM) and 5-O-(trans-3,4-
dihydroxycinnamoyl)-D-quinic acid (NCA, 10 µM) accelerated and increased the extent of recovery of both 
hippocampal synaptic transmission and synaptic plasticity after exposure to oxygen–glucose deprivation 
(OGD), modelling ischemia. (A) A period of 7 min of OGD (red bar) caused a profound depression of 
hippocampal synaptic transmission, measured as the slope of field excitatory postsynaptic potentials (fEPSP) 
recorded extracellularly in the stratum radiatum of the CA1 area upon stimulation of the afferent Schaffer 
collaterals, without appreciable modification (< 15% around average) of the presynaptic volley amplitude 
throughout the whole protocol (data not shown). (A) Upon glucose and oxygen readmission (re-oxygenation), 
there was a discrete recovery of synaptic transmission in control conditions (no added drugs), whereas this 
recovery upon re-oxygenation was more robust in the presence of either CA (10 µM; blue symbols) or NCA 
(10 µM; green symbols), added when indicated by the arrow. (B,C) Representative superimposed fEPSPs 
before OGD (filled lines), 8 min after OGD (red/orange dashed lines) and upon reoxygenation, 24 min 
after OGD (dotted lines) in the absence (B) and in the presence of 10 µM NCA control conditions (C). (D) 
Quantification of fEPSP slopes between 20 and 25 min of re-oxygenation after OGD (D). The average time 
course experiments of LTP induction (E), i.e. the variation of fEPSP slope over time upon induction of LTP with 
a high-frequency stimulation train (HFS: one train of 100 pulses delivered at 100 Hz) in hippocampal slices 
subjected to OGD followed by re-oxygenation recovery revealed that LTP magnitude was discrete in slices not 
exposed to any drug (control, black symbols) but was more evident in slices treated with CA (10 µM) or NCA 
(10 µM) during re-oxygenation (H). (F,G) Representative superimposed fEPSPs before (filled lines) and 58 min 
after HFS (dotted lines) in the absence (F) and in the presence of 10 µM NCA control conditions (G). Data 
are mean ± S.E.M. of 3–8 experiments. * p < 0.05 (or exact p value) versus control using a Kruskal Wallis test 
followed by a Dunn’s post hoc multiple comparison test. Please note that the recordings from panels B and F are 
from the same slice in the absence of added drugs and the recordings from panels B and F are from the same 
slice in the presence of 10 uM NCA applied from reoxygenation onwards.
6
Vol:.(1234567890)
Scientific Reports |        (2021) 11:10488  | https://doi.org/10.1038/s41598-021-89964-0
www.nature.com/scientificreports/
receptor over-function15, decaffeinated coffee has also been reported to display health  benefits24,50. This highlights 
the importance of defining the impact on the synaptic function of the most abundant chlorogenic acids present 
in coffee. The data presented in the present study show that concentrations of two different chlorogenic acids 
Figure 4.  Mice injected intracerebroventricularly (icv) with β-amyloid peptide 1–42 (Aβ1-42) displayed 
a selective disruption of hippocampal-dependent memory performance, accompanied by a paradoxical 
alteration of hippocampal synaptic plasticity, which was attenuated by exposure to the chlorogenic acids 
3-(3,4-dihydroxycinnamoyl)quinic acid (CA, 10 µM) and 5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic 
acid (NCA, 10 µM). Fifteen days after an icv challenge with Aβ1-42 (2 nmol), Aβ-treated mice (red symbols) 
displayed no alteration of spontaneous locomotion (A) assessed by the number of crossings in an open field test 
or anxiety, assessed as the time in the more aversive central area of the open field (B), compared with control 
(vehicle-treated mice; black symbols). In contrast, Aβ-treated mice displayed hippocampal-dependent memory 
deficits, as assessed in the object displacement test (C) and two-visits Y-maze test (D). Slices from vehicle-
treated mice displayed a pattern of long-term depression (LTD) after repeated low-frequency stimulation (LFS), 
which was not affected by CA (10 µM; blue symbols) (E–F) or NCA (10 µM; green symbols) (G,H). Slices from 
Aβ-treated mice displayed a shift from LTD to LTP after repeated low-frequency stimulation (LFS), which was 
attenuated by CA (10 µM) (E–F) or NCA (10 µM) (G,H). Data are mean ± S.E.M. of 4–6 experiments. * p < 0.05 
versus control using a Mann Whitney test (C,D) or a Kruskal Wallis test followed by a Dunn’s post hoc multiple 
comparison test (F,H).
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abundantly present in coffee and tested within the range estimated to be present in body fluids of individuals or 
animals exposed to doses of chlorogenic acids expected to be present in dietary components, namely  coffee42–44, 
were devoid of direct effects on hippocampal synaptic transmission and plasticity. In fact, neither synaptic 
transmission nor input–output curves were affected by chlorogenic acids; also, short-term plasticity (paired-
pulse facilitation) was unaffected, and there was no impact on the magnitude of either long-term potentiation 
(LTP) or long-term depression (LTD) in slices obtained from control mice (i.e. mice not exposed to any drug or 
perturbation expected to affect synaptic function). Altogether these observations show that chlorogenic acids 
are devoid of effects on synaptic transmission in physiological-like conditions.
In contrast to the lack of impact of chlorogenic acids on synaptic function under physiological conditions, 
chlorogenic acids alleviated the deterioration of synaptic function under pathology-like conditions. In fact, 
in slices obtained from A β-treated mice displaying a deterioration of hippocampal-dependent memory, we 
confirmed the presence of a shift from LTD into LTP following successive low-frequency stimulation  trains49. 
Notably, whereas chlorogenic acids were devoid of effects in control slices they attenuated this abnormal shift 
from LTD to LTP in slices from Aβ-treated mice. This ability of chlorogenic acids to correct this putative neu-
rophysiological trait of memory is in remarkable agreement with the ability of chlorogenic acids treatment to 
attenuate memory dysfunction in  genetic28,29 or pharmacological models of Alzheimer’s  disease30, as well as 
in patients with mild cognitive  impairment27. Since in vitro studies show that chlorogenic acids can attenuate 
overall cellular toxicity upon exposure to either A β or glutamate in cultured  neurons37–40 or neuron-like cell 
 lines41, it is likely that the presently reported ability of chlorogenic acids to attenuate synaptic dysfunction in 
hippocampal slices from A β-treated mice might be an indirect consequence of a general cytoprotection afforded 
by chlorogenic acids rather than direct synaptic effects, in view of the previously discussed lack of direct effects 
of chlorogenic acids on synaptic function in ‘physiological’-like conditions.
A particular ability of chlorogenic acids to control synaptic dysfunction in pathological-like conditions was 
further confirmed by the observation that chlorogenic acids were able to accelerate the recovery of synaptic 
transmission upon re-oxygenation after oxygen–glucose deprivation, an in vitro model of  ischemia45,46. Although 
with a limited number of experiments, the overall qualitative analysis of the data indicates that the exposure 
to chlorogenic acids during reoxygenation bolsters the recovery of synaptic transmission and the subsequent 
ability to engage synaptic plasticity phenomena. This is in accordance with the ability of chlorogenic acids to 
attenuate ischemia-induced brain damage in  rodents33–36. These in vivo studies also showed that the treatment 
with chlorogenic acids ameliorated the performance in memory-related behavioral tests of the mice subject to 
brain  ischemia35,36. Besides being in line with the proposal that hippocampal synaptic plasticity represents a 
neurophysiological basis of learning and memory processes, this is also in agreement with the presently observed 
larger magnitude of hippocampal synaptic plasticity in slices undergoing re-oxygenation in the presence of 
chlorogenic acids. However, this ability of chlorogenic acids to prevent the deterioration of synaptic function 
may result from an indirect effect of chlorogenic acids on glial cells supporting synaptic transmission rather 
than a direct effect on synaptic processes. In fact, it is well known that glial cells are affected by OGD challenges 
in hippocampal  slices51,52 and that interfering with glial targets affects the sensitivity and recovery of synaptic 
function upon  OGD53,54. Furthermore, chlorogenic acids can directly affect glial  cells31,55–58 and control cell 
damage caused by oxidative stress in cell culture  models59–61. Additionally, chlorogenic acids are devoid of effects 
on synaptic function in ‘physiological’-like conditions and the use of slices excludes the possible involvement 
of peripheral effects of chlorogenic acids that can indirectly impact brain  function62,63. This strongly supports 
a new working hypothesis that CA might affect either metabolic or antioxidant processes in  astrocytes31 or 
neuro-inflammatory-like reactivity in  microglia56 to indirectly control synaptic dysfunction upon hypoxia. This 
would be in accordance with the ability of chlorogenic acids to control antioxidant and inflammatory processes 
related to glial cells in in vivo models of  ischemia33,34. Finally, it is important to stress that, although the overall 
evaluation of the present findings is suggestive of a neuroprotective effect of chlorogenic acids in the recovery 
from OGD, the preliminary data raise some questions that will require additional experimental efforts, namely: 
(i) it is unclear why CA prompts a bimodal distribution of synaptic transmission after ODG, with some slices 
displaying a robust recovery whereas other recovered poorly; (ii) it is also unclear if a similar bimodal pattern 
would emerge if a larger number of experiments would be carried out with NCA; (iii) it is unclear if the apparent 
differences in the recovery of synaptic transmission and plasticity after OGD might result from different targets 
and/or different potencies of the different chlorogenic acids, an aspect that may be relevant for future selection 
of lead compounds for mechanistic and/or drug development studies.
In conclusion, the present study shows that chlorogenic acids only affect synaptic transmission and plasticity 
under pathological-like conditions, eventually through non-synaptic mechanisms. Since caffeine mostly affects 
synaptic transmission and plasticity controlling synaptotoxicity directly through its action on synaptically-located 
adenosine  A2A  receptors15, the present findings that chlorogenic acids exert non-synaptic neuroprotective effects 
provides a rationale to propose possible complementary neuroprotective effects of caffeine and chlorogenic acids 
to underlie the robust neuroprotection afforded by coffee consumption. Future work designed to unveil the likely 
glial targets of chlorogenic acids may pave the way to develop future pharmacological strategies to alleviate the 
burden of brain diseases. Additionally, it will be important to detail if the present conclusions on the ability of 
chlorogenic acids to prevent alterations of synaptic function are valid for both sexes, since this preliminary study 
was carried out in male mice and there are compelling evidences indicating that some neuroprotective effects of 
coffee differ between men and  women64,65.
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Materials and methods
Animals. We used 37 male C57BL\6J mice with 10–12 weeks of age, obtained from Charles River (Barcelona, 
Spain). The use of only one sex of mice in this preliminary study was only dictated by their availability associ-
ated with the utilization of different tissues of the same animals by different research groups at our research 
Center. Animals were housed under controlled temperature (23 ± 2 °C), subject to a fixed 12 h light/dark cycle, 
with free access to food and water. Animal handling followed the ARRIVE guidelines and the European Com-
munity guidelines (EU Directive 2010/63) as approved by the Ethical Committee of the Center for Neuroscience 
and Cell Biology of Coimbra. All efforts were made to reduce the number of mice used and to minimize their 
discomfort. Thus, mice were anesthetized in halothane atmosphere before decapitation and, whereas the hip-
pocampus was used in this study, other tissues were collected for other projects at our research center.
Drugs. Chlorogenic acid (CA, 3-(3,4-dihydroxycinnamoyl)quinic acid; C3878 from Sigma, Sintra, Portugal) 
and neochlorogenic acid (NCA, 5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic acid; 94,419 from Sigma) were 
selected to be tested in this study since CA is the most abundant polyphenol in coffee  beverages21 and we wished 
to confirm if any action of this main polyphenol was shared by one of its isomers also present in coffee, such as 
 NCA21. CA and NCA were made up as 10 mM stock solutions in dimethylsulfoxide and directly diluted in ACSF 
to be applied to hippocampal slices, containing less than 0.01% dimethylsulphoxide that we have previously 
confirmed to be devoid of effects on synaptic transmission and  plasticity14. Chlorogenic acids were tested at 
concentrations of 1 and 10 μM, similar to their estimated concentration in the brain and plasma upon ingestion 
of chlorogenic acids in amounts present in coffee beverages (0.6–14 μM)42–44.
Electrophysiology. Following decapitation after halothane-induced anesthesia, the brain was quickly 
removed and placed in ice-cold, oxygenated (95%  O2, 5%  CO2) artificial cerebrospinal fluid (ACSF; in mM: 124.0 
NaCl, 3.0 KCl, 1.25  Na2HPO4, 26.0  NaHCO3, 2.0  CaCl2, 1.0  MgCl2, 10.0 glucose). Slices (400 μm-thick) from 
the dorsal or ventromedial hippocampus were cut transverse to the long axis of the hippocampus and allowed to 
recover in oxygenated ACSF at room temperature for at least 1 h prior to recording, when they were transferred 
to a submerged chamber and superfused at 3 mL/min with oxygenated ACSF kept at 30.5 °C.
The extracellular recording of field excitatory post-synaptic potentials (fEPSP) was as previously 
 described14,16–18 with a bipolar concentric electrode placed in the proximal CA1 stratum radiatum for stimula-
tion of the Schaffer collaterals and the recording electrode, filled with 4 M NaCl (1–2 MΩ resistance), was placed 
in the CA1 stratum radiatum targeting the distal dendrites of pyramidal neurons. Stimulation was performed 
using either a Grass S44 or a Grass S48 square pulse stimulator (Grass Technologies, RI, USA), every 20 s with 
rectangular pulses of 0.1 ms. After amplification (ISO-80, World Precision Instruments, Hertfordshire, UK), 
the recordings were digitized (BNC-2110, National Instruments, Newbury, UK), averaged in groups of 3, and 
analyzed using the WinLTP version 2.10 software (WinLTP Ltd., Bristol, UK)66. The intensity of stimulation was 
chosen between 50 and 60% of maximal fEPSP response, determined on the basis of input/output curves in which 
the fEPSP slope was plotted versus stimulus intensity. Alterations of synaptic transmission were quantified as 
the % modification of the average value of the fEPSP slope taken from 15 to 20 min after the beginning of drug 
application, in relation to the average value of the fEPSP slope during the 5 min that preceded drug application 
through the superfusion solution.
The paired-pulse ratio was investigated by applying two pulses with an inter-pulse interval of 25 or 50 ms. 
Long-term potentiation (LTP) was induced by a high-frequency stimulation train (100 Hz for 1 s), as previously 
 described14,16–18. LTP magnitude was quantified as the percentage change between the average slope of the five 
fEPSPs taken between 50 and 60 min after LTP induction in relation to the average slope of the fEPSP meas-
ured during the 10 min that preceded LTP induction. Long term depression (LTD) was induced as previously 
 described49,67 in ventromedial hippocampal slices with 3 trains of 10 min stimulation at 2 Hz separated by 10-min 
intervals, with recordings performed at 32ºC. LTD magnitude was calculated as the percentage of change of fEPSP 
slope 50–60 min after completing LTD induction compared to baseline fEPSP (10 min before beginning LTD 
induction). The effect of drugs on synaptic plasticity was assessed by comparing LTP or LTD magnitude in the 
absence and presence of the drug in experiments carried out in different slices from the same animal.
In vitro modelling of ischemia. The in vitro ischemia model consisted of a brief oxygen/glucose dep-
rivation (OGD) applied directly to the superfused hippocampal slices, as previously  described45,46. The OGD 
challenge consisted of replacing the oxygenated ACSF with an ACSF with 7 mM sucrose/3 mM glucose instead 
of 10 mM glucose and saturated with 95%  N2/5%  CO2, for 7 min, and thereafter resuming superfusion with the 
10 mM glucose, oxygenated ACSF (re-oxygenation period). OGD causes a depression of synaptic transmission, 
which can recover totally or partially according to the duration of the OGD  challenge46; we selected a duration 
of 7 min which caused a partial recovery of synaptic transmission on re-oxygenation, reaching values < 25% of 
the initial fEPSP magnitude in control slices (no added drugs), which was accompanied by a non-appreciable 
modification (< 15% around average) of the presynaptic volley amplitude throughout the protocol. When testing 
the effect of chlorogenic acids on OGD recovery, chlorogenic acids were only added on re-oxygenation onwards, 
i.e. they were absent prior to and during the OGD challenge; the recovery of synaptic transmission on re-oxy-
genation was quantified 20–25 min after re-oxygenation. The magnitude of the fEPSP slope was then adjusted to 
circa 50% of the initial fEPSP amplitude and the slices were subject to an LTP-induction protocol to assess LTP 
magnitude 60 min after the high-frequency train, as described above.
Ex-vivo modelling of Alzheimer’s disease. Although there are no faithful animal models of Alzheimer’s 
disease (AD), intracerebroventricularly (icv)-injected Aβ1-42 might model early  AD68, since it recapitulates the 
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two main features of early AD, namely the impairment of reference memory and of synaptic  function18,68–70. The 
Aβ1-42 peptide fragments (Bachem, Bubendorf, Germany) were dissolved in water to obtain a solution mostly 
composed of Aβ  oligomers68 with a final concentration of 2.25 mg/mL. After anesthesia, mice were icv injected 
over a period of 15 min, with either a single dose of 2 nmol in 4 µL of Aβ1-42 or the same volume of water (vehicle, 
which caused no behavioral or neurochemical effects, similarly to the administration of scrambled Aβ42-1,  see68). 
This apparently high dose of Aβ1-42 actually translates into 5–30 pmol levels of Aβ1-42 within the hippocampus, 
causing synaptic alterations and  dysfunction18,68, without evidence of cellular  damage68. Behavioral analysis was 
performed 14 days after Aβ1-42 or vehicle administration, at a time when spatial reference memory is selectively 
affected in this icv-Aβ1-42  model68. Behavior analysis was carried out as previously  described16,18. Spontaneous 
locomotion was first monitored in an open-field apparatus. Hippocampal-dependent spatial reference memory 
was assessed with the object displacement test, using the same arena in a room (8 lx) with visual cues, where 
mice were first exposed to two identical objects for 3 min and 90 min later one of the objects was repositioned 
in the second session, where the interaction of mice with the objects was measured during 3 min. Hippocampal-
dependent spatial reference memory was further assessed using a modified version of the Y maze test where we 
scored the number of entries and the time spent in the novel arm as a measure of spatial memory in a second 
8 min visit to the maze 90 min after a first 8 min visit where one of the arms was  inaccessible16,18. Mice were then 
sacrificed for preparation of hippocampal slices for electrophysiological recordings, as described above.
Statistics. Values are presented as mean ± S.E.M. with the number of determinations (n, i.e. slices from dif-
ferent mice). The comparison of two experimental conditions was performed using a Mann Whitney test or a 
Wilcoxon Signed Rank test. Otherwise, statistical analysis was performed by a Kruskal Wallis test followed by a 
Dunn’s post hoc multiple comparison test. P < 0.05 was considered to represent statistical significance.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request.
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